What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

[11] Moses D(1992)Analysis of cancers missed at screening mammography Radiology 184 613-617

[12] Shnier R(1996)Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution Radiology 198 795-805

[13] Kirkham AP(2011)Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients Eur J Radiol 77 340-345

[14] Emberton M(2005)The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 1228-1242

[15] Allen C(2008)Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study Urology 72 859-863

[16] Delongchamps NB(2013)Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer J Urol 190 502-508

[17] Rouanne M(2012)Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer BJU Int 110 E783–8-2038

[18] Flam T(2012)Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected J Urol 187 2032-908

[19] Villeirs GM(2008)Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers Radiology 249 900-872

[20] Oosterlinck W(1994)MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis Am J Roentgenol 162 865-244

[11] Moses D(1992)Analysis of cancers missed at screening mammography Radiology 184 613-617

[12] Shnier R(1996)Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution Radiology 198 795-805

[13] Kirkham AP(2011)Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients Eur J Radiol 77 340-345

[14] Emberton M(2005)The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 1228-1242

[15] Allen C(2008)Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study Urology 72 859-863

[16] Delongchamps NB(2013)Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer J Urol 190 502-508

[17] Rouanne M(2012)Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer BJU Int 110 E783–8-2038

[18] Flam T(2012)Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected J Urol 187 2032-908

[19] Villeirs GM(2008)Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers Radiology 249 900-872

[20] Oosterlinck W(1994)MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis Am J Roentgenol 162 865-244